Download PDF
Dtsch Med Wochenschr 2013; 138(14): 725-727
DOI: 10.1055/s-0032-1332867
Pneumologie | Commentary
Pneumologie, Infektiologie
© Georg Thieme Verlag KG Stuttgart · New York

Tuberkulose: Neue Therapieoptionen und aktualisierte Therapieempfehlungen

Tuberculosis: new treatment options and updated recommendations
T. Schaberg
1   Zentrum für Pneumologie, Diakoniekrankenhaus Rotenburg
› Author Affiliations
Further Information

Publication History

Publication Date:
26 March 2013 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Tuberkulose

Keywords

tuberculosis
 

  • Literatur

  • 1 Conde MB, Efron A et al. Moxifloxacin versus ethambutol in the initial treatment of tuberculosis. Lancet 2009; 373: 1183-1189
    CrossrefPubMedGoogle Scholar
  • 2 Diacon AH, Donald PR, Pym A et al. Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis. Antimicrob Agents Chemother 2012; 56: 3271-3276
    CrossrefPubMedGoogle Scholar
  • 3 Diacon AH, Pym A et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med 2009; 360: 2397-2405
    CrossrefPubMedGoogle Scholar
  • 4 Gler MT, Skripconoka V et al. Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med 2012; 366: 2151-2160
    CrossrefPubMedGoogle Scholar
  • 5 Robert Koch-Institut. Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2010. Berlin: Robert Koch-Institut; 2012
    Google Scholar
  • 6 Schaberg T, Bauer T, Castell S et al. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK) und Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin (DGP). Empfehlungen zur Therapie, Chemoprävention und Chemoprophylaxe der Tuberkulose im Erwachsenen- und Kindesalter. Pneumologie 2012; 66: 133-171
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Skripconoka V, Danilovits M, Pehme L et al. Delamanid improves outcomes and reduces mortality for multidrug-mesistant tuberculosis. Eur Respir J 27.09.2012; [Epub ahead of print], doi: DOI: 10.1183/09031936.00125812.
    PubMedGoogle Scholar
  • 8 Sterling TR, Villarino ME, Borisov AS et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011; 365: 2155-2166
    CrossrefPubMedGoogle Scholar
  • 9 Wang JY, Wang JT, Tsai TH et al. Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis. Int J Tuberc Lung Dis 2010; 14: 65-71
    PubMedGoogle Scholar
  • 10 World Health Organization. Global tuberculosis report 2012. http://www.who.int/tb/publications/global_report/gtbr12_main.pdf
    Google Scholar